May 10th extension to reach 2.5mil stock holder equity, page-3

Endorsed by nurses
115 hospitals + modest controlled growth in numbers
Better operation of process (nurses claim)
Better targeting ( company claim)
Gone from 250 mth to 350 mth sales of filter
Teething process of signing up initial hospitals finished
No alternative
Potentially highly profitable with modest volume
Only servicing the most minuscule number of patients in a massive market
Slightly better performance and it's more cost effective than drugs for greater HF community especially in outpatient setting.
Applicable outside HF
Modest Revenue
Valued as going broke
Really modest capital requirements
extension granted

V

Complications /Clotting??
HF patients very sick medical emergency related or unrelated at the drop of a hat.
Skill and diligence need to operate therapy
Finance overhang

Modest Evidence of accelerating sales. What happens??
Way oversold even given more financing and really pessimistic attitude to risk on available info.
Insiders???